PolyCrystalLine co-hosts Bologna Convention on crystal forms

Bologna, Italy: – Crystalline form specialist CRO PolyCrystalLine announced today it would once again help organize the latest Bologna Convention on Crystal Forms.

The eighth convention will take place June 14-16, 2015, in central Bologna. The three-day event will focus on crystals targeted for the food and pharma industries, along with the expanding area of nutraceuticals. Aspects related to nucleation, crystal growth, crystal forms and amorphous solids will also be discussed.

Advanced crystal forms

As in past events, the workshop will be jointly organized by the University of Bologna’s Crystal Engineering Group (http://www.ciam.unibo.it/crystal_engineering) and by PolyCrystalLine s.r.l.

Dr. Stefano Luca Giaffreda, of University of Bologna, formed PolyCrystalLine as a company to explore commercial opportunities from the University’s advanced work in crystal forms.

“We are delighted to be associated with this event,” said Dr. Giaffreda.

Molecular crystalline materials

“The Bologna Convention on Crystal Forms has established its place as a valuable forum to explore latest concepts and knowledge in crystal engineering and molecular crystalline materials.”

University of Bologna Associate Professor Fabrizia Grepioni will chair the conference, which will include presentations from Prof. Bill Jones (Cambridge University), Prof. Sally Price (University College London), Prof. Christer Aakeröy (Kansas State University), Prof. Giancarlo Cravotto (University of Torino), Dr. Bernd Hinrichsen (BASF, Germany), Dr. Susan Reutzel-Edens (Eli Lilly & Company) and Dr. Fabia Gozzo (Excelsus Structural Solutions, Belgium).

About PolyCrystalLine

PolyCrystalLine s.r.l. has rapidly established prominence in research and characterization of crystal forms and solid-state compounds, particularly in the pharmaceutical field.

The company has its roots in academia, building on research and collaborative networks to form a business. Academic knowledge is combined with business skills, employing a close relationship with scientific methodology to construct original, forward-thinking approaches to solve technical, patenting and commercial problems.

PolyCrystalLine’s extensive experience in the characterization of solid-state compounds and the study of polymorphism has been leveraged into development of explicit and adaptable research protocols that can be adjusted to meet the requirements of the pharmaceutical industry. It investigates the thermal behavior of pharmaceutical compounds through a wide range of methods including X-ray powder diffraction, calorimetric, thermo gravimetric and evolved gas analysis.

The company is able to meet a diverse range of research needs and budget requirements, from comprehensive analysis of APIs and compounds/solvates to rapid low cost screening and studies that involve patent issues.

It can provide crystallization processes utilising modular approaches ranging from milligrams to half kilogram scale, along with expert knowledge in regards to the optimization of different parameters during the crystallization processes to achieve desired crystal forms, yields, particle size, etc.

PolyCrystalLine clients include AET, Bracco, Chemi, DeveloPharma, Dipharma, Novartis, Polpharma, Rivopharm and Zach System.